Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Gene Wallenstein"'
Autor:
Vibeke Strand, Jeffrey Kaine, Rieke Alten, Gene Wallenstein, Annette Diehl, Harry Shi, Rebecca Germino, Christopher W. Murray
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-15 (2020)
Abstract Background Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). We examined the degree to which Patient Global Assessment of Disease Activity (PtGA) was driven by patient-reported assessments of pain
Externí odkaz:
https://doaj.org/article/4747d3881ccd4abbb79175d33b0c450b
Autor:
George W. Reed, Robert A. Gerber, Ying Shan, Liza Takiya, Kimberly J. Dandreo, David Gruben, Joel Kremer, Gene Wallenstein
Publikováno v:
Rheumatology and Therapy, Vol 6, Iss 4, Pp 573-586 (2019)
Abstract Introduction No published studies exist comparing the effectiveness of tofacitinib with other advanced therapies for the treatment of rheumatoid arthritis (RA) in real-world clinical practice. Here, we report differences in effectiveness of
Externí odkaz:
https://doaj.org/article/497a18ec2df141b19969821dfab2d550
Autor:
Evelien Bergrath, Robert A. Gerber, David Gruben, Tatjana Lukic, Charles Makin, Gene Wallenstein
Publikováno v:
International Journal of Rheumatology, Vol 2017 (2017)
Objective. To compare the efficacy and tolerability of tofacitinib, an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA), as monotherapy and combined with disease-modifying antirheumatic drugs (DMARDs) versus biological DMARD
Externí odkaz:
https://doaj.org/article/21c782550cd24a0c8dea63f818a34c3b
Autor:
Gene Wallenstein, Gaelle Klingelschmitt, Elisabetta Damonte, Michael J. Levy, Cristina Costantino, D. Di Maio, H. Christian von Büdingen, Ursula Becker, Lech Szczechowski, Alan Haycox
Publikováno v:
Multiple sclerosis and related disorders. 57
Background To date, no specific scales have been developed to explore the impact of neuromyelitis optica spectrum disorder (NMOSD)-related disability on quality of life (QoL). The Expanded Disability Status Scale (EDSS) and the EuroQol 5-dimensions (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10182b9558cb0e52a841db03039f2eba
https://pubmed.ncbi.nlm.nih.gov/35158426
https://pubmed.ncbi.nlm.nih.gov/35158426
Autor:
Margaret A, Chang, Audrey, Kapre, Derrick, Kaufman, David R, Kardatzke, Melvin, Rabena, Shienal, Patel, Ashwini, Bobbala, Shamika, Gune, Anne, Fung, Gene, Wallenstein
Publikováno v:
JAMA Ophthalmology. 140:771
The port delivery system (PDS) with ranibizumab has demonstrated noninferior and equivalent efficacy compared with monthly intravitreal injections of ranibizumab, an anti-vascular endothelial growth factor (VEGF) agent, in patients with neovascular a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d8e1b516fe337397d81e888032033b2
https://doi.org/10.1001/jamaophthalmol.2022.1091
https://doi.org/10.1001/jamaophthalmol.2022.1091
Autor:
Vibeke, Strand, Désirée, van der Heijde, Yoshiya, Tanaka, Edward, Keystone, Joel, Kremer, Cristiano A F, Zerbini, Mario H, Cardiel, Stanley, Cohen, Peter, Nash, Yeong-Wook, Song, Dana, Tegzová, David, Gruben, Gene, Wallenstein, Carol A, Connell, Roy, Fleischmann
Publikováno v:
Clinical and experimental rheumatology. 38(5)
Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). Here we present data from the completed Phase 3 randomised controlled trial (RCT) ORAL Scan (NCT00847613), which evaluated the impact of tofacitinib on pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::065bf061f3096fc56f7f081e026b3dbc
https://pubmed.ncbi.nlm.nih.gov/31858963
https://pubmed.ncbi.nlm.nih.gov/31858963
Autor:
James K. Walsh, Judy Caron, Andrew D. Krystal, Robert Rubens, Kendyl Schaefer, James M. Roach, Thomas Wessel, David A. Amato, Thomas Roth, Gene Wallenstein
To evaluate 6 months' eszopiclone treatment upon patient-reported sleep, fatigue and sleepiness, insomnia severity, quality of life, and work limitations.Randomized, double blind, controlled clinical trial.54 research sites in the U.S.830 primary ins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4915d3ebfe5435cf9e0ff46c1dca7f7
https://europepmc.org/articles/PMC1978384/
https://europepmc.org/articles/PMC1978384/
Autor:
Gene Wallenstein
An immensely fascinating look at the origins and evolutionary purpose of human pleasureFrom our enjoyment of music to our cravings for chocolate, from our love for children and family to our attraction to things of beauty, this book embarks on an int